HEALTH
Don’t Try ARBs for Severe COVID, Trial Indicates
![Don’t Try ARBs for Severe COVID, Trial Indicates](https://connecticutnewspress.com/wp-content/uploads/2024/07/14358-dont-try-arbs-for-severe-covid-trial-indicates-780x470.jpg)
MedPage Today) — The angiotensin receptor blocker (ARB) losartan led to hypotension and failed to improve mortality in patients hospitalized for acute COVID-19, according to the randomized, prospective — and prematurely terminated — ARBs…